Physician profile
Deanna A Risher
NPI 1144584467
$1,144.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $174 · 2021: $179 · 2022: $289 · 2023: $135 · 2024: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $281.13 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $195.82 | 2019-2024 | Acuvue |
| Coopervision INC. | $143.08 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $141.22 | 2022-2024 | Infuse |
| Abbvie INC. | $116.09 | 2022 | |
| Horizon Therapeutics Plc | $60.22 | 2022 | |
| Rxsight INC | $50.12 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Alcon Vision LLC | $47.70 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $45.78 | 2020 | |
| Allergan, INC. | $27.44 | 2021-2022 | |
| Oyster Point Pharma, INC. | $19.71 | 2022 | |
| Optos, INC. | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Risher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.